CIRM Approves New and Updated Funding Programs, Awards $26.5 Million for Clinical Research and Development
On Mar. 27, 2025, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
University of Alberta life sciences research gets a $100 Million lift
On Mar. 4, 2025, the Government of Alberta announced it had contributed $100 million in capital funding to…
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
On Jan. 30, 2025, the California Institute for Regenerative Medicine (CIRM) announced it has awarded nearly $100 million…
CIRM Awarded $29.7 Million to Advance rare pediatric disease Clinical Projects
On Nov. 21, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding $29.7 million to…
Scientists recreated mouse from gene older than animal life
On Nov. 15, 2024, researchers from Queen Mary University of London and the the University of Hong Kong…
Proteins that regulate animal stem cells are much older than animals themselves
On Nov. 15, 2024, an international research team including scientists from the Max Planck Institute reported that critical…
UT Southwestern scientists discover ancient viral DNA activates blood cell production during pregnancy
On Oct. 24, 2024, researchers from Children’s Medical Center Research Institute at UT Southwestern reported that ancient viral remnants…
Stem cells reverse woman’s diabetes — a world first
On Sept. 26, 2024, a team of scientists in Peking University in Beijing, China announced that a 25-year-old…
CIRM approved $8 million award for plasma cell disorder therapy, $27 million to boost collaboration among California researchers
On Jul. 25, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
CIRM awarded $26 million to advance clinical research across cancer, heart conditions, and rare diseases
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
Biotechnology | Diagnostics | Infectious Disease | Medicine | Neurology | Non-Profit Research | Oncology | Therapeutics
CIRM awarded $53 million to clinical research in heart failure and cystic fibrosis, supporting 10 translational projects
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
Biotechnology | Diagnostics | Disease | Neurology | Non-Profit Research | Ophthalmogy | Therapeutics
CIRM awarded $31 million to fund clinical-stage research for cancers and eye disease
On Apr. 26, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding nearly $31…
California’s Stem Cell Agency invested $25 million for discovery and preclinical research, patient support program
On Mar. 29, 2024, the California Institute for Regenerative Medicine (CIRM) announced awards that support 11 projects in…
European Commission approved first CRISPR/Cas9 gene-edited therapy, CASGEVY for reatment of SCD and TDT
On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…
CRISPR | Genomics | Stem Cell | Therapeutics
FDA approved first gene therapies to treat patients with sickle cell disease
On Dec. 8, 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing…
Vertex and CRISPR Therapeutics announced authorization of first CRISPR/Cas9 gene-edited therapy by UK MHRA for treatment of Sickle Cell Disease
On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…
Biotechnology | Diagnostics | Medical Device | Neurology | Non-Profit Research | Stem Cell | Therapeutics
California’s Stem Cell Agency invested more than $42.1 million in translational-stage research
On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…
California’s Stem Cell Agency invested $44 million to advance regenerative medicine research and manufacturing in California
On Sept. 29, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $43.8 million to fund projects aimed…
CIRM invested $50 million in clinical-stage research
On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research…
CIRM invested $26 million in research
On Mar. 27, 2023, CIRM Board approved investing nearly $26 million in 17 projects in early-stage discovery research.The…
Researchers document third known case of HIV remission involving stem cell transplant
On Feb. 15, 2023, it was reported that a 53-year-old man in Germany had become at least the…
NIH researchers used 3D bioprinting to create eye tissue
On Dec. 22, 2022, resarchers at the National Institutes of Health announced they had used patient stem cells…
First ever clinical trial of laboratory grown red blood cells being transfused into another person
On Nov. 7, 2022, the NHS Blood and Transplant (NHSBT) reported that red blood cells grown in a…
Patient with HIV achieved remission following stem cell transplant
On Jul. 27, 2022, City of Hope announced that a 66-year-old man who was diagnosed with HIV in…
Researchers documented third known case of HIV remission involving stem cell transplant
On Feb. 15, 2022, a woman with HIV who received a cord blood stem cell transplant to treat…
Brazilian HRA authorized Sorrento phase 2 pivotal clinical trial of COVI-MSCﾙ in hospitalized COVID-19 patients with ARDS
On May 20, 2021, Sorrento Therapeutics announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed…
COVID-19 can kill heart muscle cells, interfere with contraction
On Mar. 1, 2021, a study from Washington University School of Medicine in St. Louis provided evidence that…
Notch Therapeutics closed $85 million financing to develop pipeline of renewable stem cell-derived cancer immunotherapies
On Feb. 10, 2021, Notch Therapeutics closed $85 Million Series A financing to develop pipeline of renewable stem…
Sorrento announced the fourth patient was released from hospital following third infusion of stem cells
On Jan. 31, 2021, Sorrento Therapeutics announced additional positive results from its Phase 1b study of human allogeneic…
Sorrento announced positive preliminary results of phase 1b study of COVI-MSC for treatment of ICU COVID-19 patients
On Jan. 26, 2021, Sorrento Therapeutics announced positive preliminary results from its Phase 1b study of human allogeneic…